John D. Quisel - 29 Dec 2022 Form 3 Insider Report for Disc Medicine, Inc. (IRON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
03 Jan 2023, 16:00:49 UTC
Next SEC filing
29 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rahul Khara, attorney-in-fact

Key filing fact

John D. Quisel filed Form 3 for Disc Medicine, Inc. (IRON) on 03 Jan 2023.

Key facts

  • This page summarizes John D. Quisel's Form 3 filing for Disc Medicine, Inc. (IRON).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Jan 2023, 16:00.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
243,911
Exercise price
$1.01
Footnotes
F1
IRON holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
61,650
Exercise price
$2.65
Footnotes
F2
IRON holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Dec 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
168,387
Exercise price
$9.86
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

25% of the shares underlying this option vested on February 25, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Footnote F2

5,137 shares underlying this option vested on February 25, 2021, with the remaining shares vesting in 44 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Footnote F3

The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .